Logo

NimbleGen Systems Renames German Subsidiary

Dec 03, 2004

NEW YORK, Dec. 3 (GenomeWeb News) - NimbleGen Systems has renamed Chemogenix, its German-based chemistry research and development subsidiary, to NimbleGen Systems.

 

The name change was made to bring the privately held company's operations under one name, NimbleGen Systems said in a statement. NimbleGen, the Madison, Wisc.-based microarray firm, has operations in the US, Iceland, and Germany.

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.